Press Release

Pseudomonas Aeruginosa Infection Treatment Market to Grow with a CAGR of 6.14% through 2028

Increasing incidence of infections associated with it such as pneumonia, cystic fibrosis, and urinary tract infections are expected to drive the Global Pseudomonas Aeruginosa Infection Treatment Market growth in the forecast period, 2024-2028.


According to TechSci Research report, “Pseudomonas Aeruginosa Infection Treatment  Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Pseudomonas Aeruginosa Infection Treatment Market stood at USD 1.43 Billion in 2022 and is anticipated to grow with a CAGR of 6.14% through 2028. The major factors such as the increasing incidence of infections associated with it such as pneumonia, cystic fibrosis, and urinary tract infections, the increasing development of products, increasing antibacterial resistance, and growing R&D activities are driving the growth of the Pseudomonas aeruginosa infection market. The prevalence of hospital-acquired infections has increased in recent years. According to an article published in the National Library of Medicine in August 2022, the estimated worldwide incidence of community-acquired pneumonia varies between 1.5 and 14 cases per 1000 person-years, and this is affected by geography, season, and population characteristics. In the United States, the annual incidence is 24.8 cases per 10,000 adults, with higher rates as age increases. As a result of the increased burden of P. aeruginosa infection, the demand for its treatment is predicted to rise over the projection period, thereby boosting the growth of the studied market.

Furthermore, growing research and development activities on pseudomonas aeruginosa infection are expected to support market expansion over the forecast period. For instance, according to ClinicalTrials.gov updated in October 2022, a study titled "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa" is under phase II trials and expected to be completed by 2024. Thus, such a study is expected to bring an advanced product for treating pseudomonas aeruginosa infection, thereby boosting the market's growth.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Pseudomonas Aeruginosa Infection Treatment Market

 

The Global Pseudomonas Aeruginosa Infection Treatment Market is segmented into Medication Type, Drug Type, Route Of Administration, Distribution Channel, and company.

Based on the Product, the Transdermal patches segment is anticipated to witness substantial market growth throughout the forecast period. The Global Pseudomonas Aeruginosa Infection Treatment Market is poised for significant growth propelled by the increasing prominence of transdermal patches. These innovative patches, combining pharmaceuticals with specialized delivery systems, offer a convenient and non-invasive approach to drug administration. The rising demand for patient-friendly alternatives to traditional dosage forms, such as oral medications or injections, positions transdermal patches as a key driver in the market. Transdermal patches provide controlled and sustained drug release, improving treatment adherence and minimizing fluctuations in drug levels. They offer advantages in terms of ease of use, reduced side effects, and enhanced patient comfort. Additionally, the patches cater to the growing preference for self-administration, empowering patients to manage their healthcare more independently.

Based on the Distribution Channel segment, the Hospital Pharmacies segment has been the dominant force in the market. Hospital Pharmacies are poised to play a pivotal role in propelling the growth of the Global Pseudomonas Aeruginosa Infection Treatment Market. As primary points of dispensing medications within healthcare institutions, hospital pharmacies are critical stakeholders in the effective management and treatment of infectious diseases, including those caused by Pseudomonas Aeruginosa. The demand for specialized and advanced infection treatments is significantly high within hospital settings, where patients with severe infections often receive medical care. Hospital pharmacies are crucial in ensuring the availability and timely dispensing of cutting-edge Pseudomonas Aeruginosa infection treatments, contributing directly to patient care and recovery.

 

Major companies operating in Global Pseudomonas Aeruginosa Infection Treatment Market are:

  • Allergan, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • AstraZeneca PLC.
  • Merck & Co. Inc.
  • Bristol-Myers Squibb Co.
  • Janssen Pharmaceuticals Inc.
  • Lupin Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Sanofi SA.

 Download Free Sample Report

Customers can also request 10% free customization on this report 

“The prevalence of hospital-acquired infections has increased in recent years. Growing research and development activities on pseudomonas aeruginosa infection are expected to support market expansion over the forecast period. Various organic and inorganic strategies by the market players are likely to support the growth of the market. The growing prevalence of pseudomonas aeruginosa infection and rising drug development and discovery activities, are expected to propel the growth of the market over the forecast period. However, drug resistance ability of pseudomonas aeruginosa may restraint the market growth over the forecast period.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

 

Pseudomonas Aeruginosa Infection Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Medication Type (Monotherapy, Combination Therapy), By Drug Type (Aminoglycoside, Cephalosporin, Carbapenem, Monobactam, Others), By Route Of Administration (Nasal, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition”, has evaluated the future growth potential of Global Pseudomonas Aeruginosa Infection Treatment  Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Pseudomonas Aeruginosa Infection Treatment Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com 


Relevant News